MUMBAI, India, Aug. 10 -- Intellectual Property India has published a patent application (202647091346 A) filed by National Cancer Center; and Arc Therapies Inc. on July 28, 2026, for Survivor T Cells, Survivor T Cell Population, And Pharmaceutical Composition.
Inventors include Nishikawa, Hiroyoshi; and Watanabe, Keisuke.
The application for the patent was published on July 31, 2026, under issue no. 31/2026.
Abstract: The present disclosure provides cells that are competitive with respect to cancer cells, without experiencing starvation or exhaustion, even in glucose-depleted environments. Specifically, the present disclosure provides survivor T cells with enhanced glucose uptake capacity. The T cells are modified so as to express a glucose transporter and/or configured such that the expression of a glucose transporter is enhanced. Also provided are a cell population including such cells, a pharmaceutical composition, and a treatment method.
Disclaimer: Curated by HT Syndication.
